52 Week Range
As of on the XETRA ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Wacker Chemie FY Net Loss At EUR 630 Million
Wacker Chemie Extends Contract Of CFO Tobias Ohler
Wacker Chemie Sets Cost-Cutting Measures
Wacker Chemie AG is a Germany-based manufacturer of specialty chemical products. It operates through four segments: Silicones, Polymers, Biosolutions and Polysilicon. The Silicones segments provides silane, silicone fluids, emulsions, elastomers, sealants and resins to pyrogenic silicas; the Polymers segment offers a range of polymeric binders and additives along with customized services; the Biosolutions segment serves the food, pharmaceutical, life science and agrochemical industries and produces fermenter cysteine and bioengineered cyclodextrins, among others, and the Polysilicon segment manufactures high-purity polysilicon for the solar technology and semiconductor-electronics industries.
Independent Chairman of the Supervisory Board
Chief Executive Officer, President, Member of the Executive Board
Deputy Chairman of the Board, Employee Representative
Chief Financial Officer, Member of the Executive Board, Member of the Supervisory Board
Member of the Executive Board
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
* FOR 2019, SALES OF EUR 4.93 BILLION WERE DOWN 1 PERCENT YEAR OVER YEAR
Wacker Chemie <WCHG.DE> is drawing up cost cutting plans in response to falling prices of polysilicon, a step which will include job cuts, chief financial officer Tobias Ohler told Germany's Boersen-Zeitung.
German specialty chemicals maker Wacker Chemie on Thursday said it had bought a quarter in British battery materials maker Nexeon Ltd.
* Shares down 1.5 pct (Adds details on polysilicon market, shares)
German specialty chemicals maker Wacker Chemie on Tuesday said it expects its core profit to decline by up to a fifth this year, pointing to lower selling prices for polysilicon, which it supplies to the solar industry.
* SAYS OBTAINS FDA APPROVAL TO MANUFACTURE THE DRUG SUBSTANCE IN RETAVASE, A THROMBOLYSIS MEDICATION BY CHIESI Source text: https://www.wacker.com/cms/en/home/index.jsp Further company coverage:
Wacker Chemie will see a significant hit to volumes of polysilicon in the fourth quarter as a result of an outage at its plant in Charleston, Tennessee, following an explosion at the site last month, its chief financial officer said.
* Shares indicated 2.6 pct higher (Recasts, adds context on results, shares)
German specialty chemicals maker Wacker Chemie on Thursday raised its outlook for core earnings for the second time in three months, pointing to "markedly higher" demand as well as income from its stake in Siltronic.
German specialty chemicals group Wacker Chemie's <WCHG.DE> polysilicon plant in Charleston, Tennessee, is likely to remain out of commission for several months after an explosion this month, it said on Wednesday.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.